Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer: North Japan Lung Cancer Group Trial 0802Yosuke Kawashima, Toshihiro Nukiwa, Toshiro Suzuki et al.|Respiratory Investigation|2014Cited by 3
A phase I/II study of gemcitabine (GEM) and carboplatin (CBDCA) biweekly combination chemotherapy for inoperable stage IIIB, IV non-small-cell lung cancer (NSCLC) (final report)Yukihiro Hasegawa, Kazuhiro Okumura, Shingo Takanashi et al.|Journal of Clinical Oncology|2005Cited by 3
A phase I study of biweekly combination chemotherapy with gemcitabine (GEM) and carboplatin (CBDCA) for inoperable stages IIIB and IV non-small-cell lung cancer (NSCLC)Yukihiro Hasegawa, Kazuhiro Okumura, Kageaki Taima et al.|Journal of Clinical Oncology|2004Cited by 1